ABOUT US
TECHNOLOGY
PIPELINE
INVESTORS
Еще
Jan 30, 2024
Estrella Immunopharma Announces $1 Million Share Repurchase Authorization
Jan 24, 2024
Estrella Immunopharma Announces Publication in Blood Demonstrating ARTEMIS T Cell’s Potential in Addressing Acute Myeloid Leukemia (AML)
Sep 29, 2023
TradeUP Acquisition Corp. and Estrella Biopharma, Inc. Announce Completion of Business Combination
Mar 8, 2023
Estrella Biopharma Announces FDA Clearance of IND Application for Phase I/II Clinical Trial (Starlight-1) of EB103, a CD19-Targeted ARTEMIS® T Cell Therapy, to Patients with B-Cell Lymphomas
Nov 14, 2022
Imugene’s onCARlytics combination with Estrella’s CD19-Redirected ARTEMIS® T Cells presented at SITC Annual Meeting
Oct 3, 2022
Estrella Biopharma, Inc., a biopharmaceutical company to Become a Publicly Traded Company Via Merger with TradeUP Acquisition Corp.